Gene expression profiling in myelodysplastic syndrome after SPARC overexpression associated with Ara-C

By            

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 2072-2082

Spandidos Publications

Access to resources Recommend Favorite

High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study

By Tedeschi Alessandra   Montillo Marco   Strocchi Elena   Cafro Anna   Tresoldi Elisabetta   Intropido Liliana   Nichelatti Michele   Marbello Laura   Baratè Claudia   Camaggi Carlo   Morra Enrica  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 771-779

Springer Publishing Company

Access to resources Recommend Favorite

Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

By Prebet Thomas   Charbonnier Aude   Gelsi-Boyer Véronique   Mozziconacci Marie Joelle   Blaise Didier   Vey Norbert  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1538-1540

Informa Healthcare

Access to resources Recommend Favorite

Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: A case report

By      

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 422-424

Spandidos Publications

Access to resources Recommend Favorite

Treatment of Myelodysplastic Syndrome Transforming into Acute Myelogenous Leukemia with Azacytidine: A Retrospective Study from Cancer Centre in Northern India

By Suresh P.  

Indian Journal of Hematology and Blood Transfusion, Vol. 26, Iss. 3, 2010-09 ,pp. : 114-114

Springer Publishing Company

Access to resources Recommend Favorite